Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Spectral Diagnostics, Inc.

This article was originally published in The Gray Sheet

Executive Summary

Toronto-based cardiac diagnostics company completes its offering of Special Convertible Securities. The offering will result in the issue of 1 mil. common shares of the stock and will net the firm $21.7 mil (at current exchange rates). First Marathon, Burns Fry, and Thomson Kernaghan are underwriting. Spectral plans to use the proceeds to fund its Point-of-Care line of cardiac diagnostics, which feature rapid format panel tests for diagnosing the cause of chest pain



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts